Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,607 total articles

Future Money Acquisition Corporation Announces Receipt of Nasdaq Delinquency Notice Regarding Delayed Form 10-Q Filing

Future Money Acquisition Corporation Announces Receipt of Nasdaq Delinquency Notice Regarding Delayed Form 10-Q Filing

Future Money Acquisition Corporation announced that it received a deficiency letter from Nasdaq due to its failure to timely file its Form 10-Q for the fiscal quarter ending July 31, 2026. The company has 60 days to submit a compliance plan and potentially up to 180 additional days to regain compliance, but uncertainties remain regarding its abilit…

WISeKey Announces Planned Effectiveness of Redomiciliation from Switzerland to the British Virgin Islands

WISeKey Announces Planned Effectiveness of Redomiciliation from Switzerland to the British Virgin Islands

WISeKey International Holding Ltd announced the planned legal effectiveness of its redomiciliation from Switzerland to the British Virgin Islands via a merger with its BVI subsidiary, WISeQey Corp, effective October 2, 2026. This move will see WISeKey cease as a legal entity and WISeQey continue as the surviving company, trading on Nasdaq and SIX S…

Pool Corporation Announces Director Appointment

Pool Corporation Announces Director Appointment

Pool Corporation has appointed Jean-Marc Germain, former CEO of Constellium SE, to its Board of Directors effective September 30, 2026. Germain brings extensive leadership experience from global industrial sectors and public company governance, expected to enhance Pool Corporation's strategic execution and shareholder value creation.

NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments

NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments

NervGen will restate its 2025 audited financial statements and interim 2026 quarterly results to revise the valuation of certain warrants and options. These adjustments, which reduce previously reported stock-based compensation expenses and warrant liabilities, are non-cash and will not affect the company's cash position, cash runway, or business o…

Weatherford Announces Third-Quarter 2026 Conference Call

Weatherford Announces Third-Quarter 2026 Conference Call

Weatherford International plc announced it will hold a conference call on October 21, 2026, to discuss its third-quarter 2026 financial results ending September 30. The company will release the related press release and presentation slides beforehand, available on its investor relations website. The live call will be accessible via webcast or phone…

Reminder: HHH 2026 Annual Shareholder Meeting Set for September 30

Reminder: HHH 2026 Annual Shareholder Meeting Set for September 30

Howard Hughes Holdings Inc. (NYSE: HHH) scheduled its 2026 Annual Shareholder Meeting for September 30, 2026, where leadership will discuss the company's transformation strategy focused on reducing capital intensity in its real estate subsidiary and increasing investment in its insurance subsidiary. The meeting will provide business updates and a Q…

Indonesia Energy Announces Availability of Financial Results

Indonesia Energy Announces Availability of Financial Results

Indonesia Energy Corporation Limited (NYSE American: INDO), an oil and gas exploration company focusing on Indonesia, announced the filing of its unaudited financial results for the six months ending June 30, 2026, along with the availability of its 2025 audited annual report. The reports include detailed financial statements and footnotes, accessi…

Sysco Announces Closing of C$1.5 Billion Senior Notes Offering

Sysco Announces Closing of C$1.5 Billion Senior Notes Offering

Sysco Corporation announced the closing of a C$1.5 billion senior notes offering, composed of two tranches due in 2030 and 2034, intended to finance part of the acquisition cost and related expenses for its pending acquisition of Jetro Restaurant Depot. The offering was conducted under a shelf registration statement in the U.S. and also privately p…

HUB Cyber Security Announces Receipt of Nasdaq Notification Regarding Market Value of Listed Securities Requirement

HUB Cyber Security Announces Receipt of Nasdaq Notification Regarding Market Value of Listed Securities Requirement

HUB Cyber Security Ltd. announced it received a Nasdaq notification that it does not meet the minimum Market Value of Listed Securities (MVLS) requirement of $35 million necessary to maintain listing on the Nasdaq Capital Market. The company has 180 days to regain compliance or risk delisting, while continuing its efforts to restructure, improve li…

EquipmentShare Responds to Inaccurate Short Report

EquipmentShare Responds to Inaccurate Short Report

EquipmentShare, a leading US construction equipment rental and technology company, issued a statement rejecting a short report by Blue Orca Capital, alleging mischaracterization of its business and finances. The company emphasized adherence to GAAP, independent audits, and confidence in its growth prospects and market position.

Rubico Announces Record Date of Monday, September 28 and Ex-Dividend Date of Tuesday, October 6 for Previously-Announced 0.50 Common Shares Per Common Share Stock Dividend

Rubico Announces Record Date of Monday, September 28 and Ex-Dividend Date of Tuesday, October 6 for Previously-Announced 0.50 Common Shares Per Common Share Stock Dividend

Rubico Inc., a Nasdaq-listed global shipping service provider, announces the record date of September 28, 2026, and an ex-dividend date of October 6, 2026 for its previously declared 0.50 common shares stock dividend. The company outlines due bill trading procedures and confirms the distribution will be on or about October 5, 2026. Rubico also upda…

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer

SELLAS Life Sciences announced preclinical results revealing that SLS009, their selective CDK9 inhibitor, significantly increased apoptosis and necrosis in MYC-amplified, daraxonrasib-resistant pancreatic cancer models. The combination of SLS009 with daraxonrasib or BET inhibitor ZEN3694 demonstrated synergistic effects, supporting the potential of…

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

OneMedNet Corporation will execute a 1-for-10 reverse stock split effective September 29, 2026, approved by shareholders to comply with Nasdaq Capital Market's minimum bid price rules and to potentially broaden investor interest. The reverse split reduces outstanding shares from approximately 59.3 million to about 5.9 million, with proportional adj…

Pinnacle Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing September 25, 2026

Pinnacle Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing September 25, 2026

Pinnacle Acquisition Corporation announced that starting September 25, 2026, investors will be able to trade the company's Class A ordinary shares and rights separately, following their initial trading as units in the IPO. The shares and rights will trade under the symbols 'PNAQ' and 'PNAQ.RT' respectively on the New York Stock Exchange. Pinnacle A…

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

Pharming Group announced that the U.S. FDA has accepted for Priority Review its supplemental New Drug Application seeking approval for lower doses of Joenja® (leniolisib) to treat children aged 4 years and older weighing between 13 kg and 27 kg with activated phosphoinositide 3-kinase delta syndrome (APDS). The FDA's target action date is January 3…